Literature DB >> 7573045

Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group.

M Krajinovic1, B Pinamonti, G Sinagra, M Vatta, G M Severini, J Milasin, A Falaschi, F Camerini, M Giacca, L Mestroni.   

Abstract

Idiopathic dilated cardiomyopathy is a heart muscle disease of unknown etiology, characterized by impaired myocardial contractility and ventricular dilatation. The disorder is an important cause of morbidity and mortality and represents the chief indication for heart transplantation. Familial transmission is often recognized (familial dilated cardiomyopathy, or FDC), mostly with autosomal dominant inheritance. In order to understand the molecular genetic basis of the disease, a large six-generation kindred with autosomal dominant FDC was studied for linkage analysis. A genome-wide search was undertaken after a large series of candidate genes were excluded and was then extended to two other families with autosomal dominant pattern of transmission and identical clinical features. Coinheritance of the disease gene was excluded for > 95% of the genome, after 251 polymorphic markers were analyzed. Linkage was found for chromosome 9q13-q22, with a maximum multipoint lod score of 4.2. There was no evidence of heterogeneity. The FDC locus was placed in the interval between loci D9S153 and D9S152. Several candidate genes for causing dilated cardiomyopathy map in this region.

Entities:  

Mesh:

Year:  1995        PMID: 7573045      PMCID: PMC1801493     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Sensitivity of lod scores to changes in diagnostic status.

Authors:  S E Hodge; D A Greenberg
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

2.  Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop.

Authors:  T A Manolio; K L Baughman; R Rodeheffer; T A Pearson; J D Bristow; V V Michels; W H Abelmann; W R Harlan
Journal:  Am J Cardiol       Date:  1992-06-01       Impact factor: 2.778

3.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

4.  CEPH consortium Map of chromosome 9.

Authors:  J Attwood; M Chiano; A Collins; H Donis-Keller; N Dracopoli; J Fountain; C Falk; D Goudie; J Gusella; J Haines
Journal:  Genomics       Date:  1994-01-15       Impact factor: 5.736

Review 5.  Clinical genetics of dilated cardiomyopathy.

Authors:  P J Keeling; W J McKenna
Journal:  Herz       Date:  1994-04       Impact factor: 1.443

6.  Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree.

Authors:  M Krajinovic; L Mestroni; G M Severini; B Pinamonti; F Camerini; A Falaschi; M Giacca
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

7.  Inherited cardiomyopathies.

Authors:  D P Kelly; A W Strauss
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

Review 8.  Idiopathic dilated cardiomyopathy.

Authors:  G W Dec; V Fuster
Journal:  N Engl J Med       Date:  1994-12-08       Impact factor: 91.245

9.  Echocardiographic measurements in normal subjects from infancy to old age.

Authors:  W L Henry; J M Gardin; J H Ware
Journal:  Circulation       Date:  1980-11       Impact factor: 29.690

10.  Erythrocyte tropomodulin binds to the N-terminus of hTM5, a tropomyosin isoform encoded by the gamma-tropomyosin gene.

Authors:  L A Sung; J J Lin
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

View more
  24 in total

Review 1.  Many roads lead to a broken heart: the genetics of dilated cardiomyopathy.

Authors:  J Schönberger; C E Seidman
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

2.  Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice.

Authors:  M A Sussman; S Welch; N Gude; P R Khoury; S R Daniels; D Kirkpatrick; R A Walsh; R L Price; H W Lim; J D Molkentin
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  A novel locus for autosomal-dominant dilated cardiomyopathy maps to chromosome 7q22.3-31.1.

Authors:  Jost Schönberger; Leif Kühler; Elisabete Martins; Tom H Lindner; Jose Silva-Cardoso; Michael Zimmer
Journal:  Hum Genet       Date:  2005-10-14       Impact factor: 4.132

4.  A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy.

Authors:  A Ferlini; N Galié; L Merlini; C Sewry; A Branzi; F Muntoni
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

5.  Decoding the complex genetic causes of heart diseases using systems biology.

Authors:  Djordje Djordjevic; Vinita Deshpande; Tomasz Szczesnik; Andrian Yang; David T Humphreys; Eleni Giannoulatou; Joshua W K Ho
Journal:  Biophys Rev       Date:  2014-12-10

Review 6.  The genomics of cardiovascular disorders: therapeutic implications.

Authors:  P Ferrari; G Bianchi
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 7.  [Genetics of dilated cardiomyopathy].

Authors:  L Thierfelder
Journal:  Med Klin (Munich)       Date:  1998-04-15

8.  [Classification of cardiomyopathies according to the WHO/ISFC Task Force--more questions than answers?].

Authors:  B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 9.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

10.  Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23.

Authors:  K R Bowles; R Gajarski; P Porter; V Goytia; L Bachinski; R Roberts; R Pignatelli; J A Towbin
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.